Gene variant shows promise slowing Alzheimer's
A rare genetic trait called Christchurch could delay the onset of disease
What happened
A single copy of a rare genetic variant tied to Alzheimer's disease appears to delay the onset of cognitive impairment and dementia by about five years, U.S. and Colombian researchers reported Wednesday. The study, published in the New England Journal of Medicine, offers hope that a drug emulating this variant of the APOE3 gene, dubbed the Christchurch variant, could similarly defeat or delay Alzheimer's.
Who said what
Researchers reported in 2019 that a Colombian woman from an extended family genetically predisposed to develop Alzheimer's in their 40s had fended off dementia until her 70s, seemingly because she carried two copies of the Christchurch variant. The new study found that 27 relatives with just one Christchurch gene developed symptoms around age 52, roughly five years later later than other family members with the early-onset genetic mutation.
One patient could be a fluke, but "finding 27 people" evidently shielded by the Christchurch variant "increases our confidence in the discovery — and shows the results are reproducible," the study's co-author Joseph Arboleda-Velasquez, at Mass Eye and Ear in Boston, said to The Washington Post.
What next?
Researchers have found success testing an experimental drug that imitates Christchurch in mice and are seeking authorization for human trials.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
A human foot found on Mount Everest is renewing the peak's biggest mystery
The discovery is reviving questions about who may have summited the mountain first
By Justin Klawans, The Week US Published
-
Crossword: October 22, 2024
The Week's daily crossword
By The Week Staff Published
-
Sudoku hard: October 22, 2024
The Week's daily hard sudoku puzzle
By The Week Staff Published
-
What went wrong at CVS?
Today's Big Question Pharmacy chains are in crisis
By Joel Mathis, The Week US Published
-
The 'game-changing' treatment for schizophrenia
The Explainer US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects
By Harriet Marsden, The Week UK Published
-
The audio industry is working to tackle hearing aid stigma
The Explainer Only 1 in 5 people who could benefit from hearing aids use them, according to the Hearing Loss Association of America
By Justin Klawans, The Week US Published
-
Mold, bugs at listeria-linked Boar's Head meat plant
Speed Read Food safety inspectors reported many violations at a Virginia plant that has been linked to a nationwide deli meat recall
By Peter Weber, The Week US Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
The battle for abortion buffer zones
The Explainer A 2023 law banning protests around clinics remains unenforced amid dispute over 'silent prayer'
By Harriet Marsden, The Week UK Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published